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Collaborative Drug Therapy Agreement Topics in the State of Washington: From Dispensing 
Pills to Managing Ills 
Nancy Hecox, PharmD CDP PRS 
 
Introduction 
In 1991, Washington State pharmacists were granted 
dependent prescriptive authority via collaborative drug 
therapy agreements with any practitioner licensed in the 
state of Washington authorized to prescribe legend drugs.  
 
Collaborative drug therapy agreements (CDTAs) in 
accordance with the laws (RCW 18.64.011)¹ and regulations 
(WAC 246-863-100)2 allow pharmacists prescriptive authority 
in various settings and for various purposes. There is no 
statutory authority to limit the pharmacists' prescriptive 
authority to any particular class of drugs or location of 
practice. The intent of the CDTA regulation is to increase the 
capacity and access to pharmaceutical care for the citizens of 
WA State so that health outcomes are improved. 
 
A CDTA is a prepared, written guideline or protocol algorithm 
authorizing the pharmacist to include specific prescribing 
functions into their practice. The CDTA document may 
include prescribing for the management of disease states, 
medication refills, preventative health care, medication 
reviews and emergency situations.  
 
Purpose 
This paper provides a description of the current CDTA topics 
on file with the Washington State Department of Health 
credentialing department.  
 
Having reviewed hundreds of CDTAs, it is possible to 
categorize the list into practice settings, noting that the CDTA 
itself could stand in any desired setting. This paper includes a 
sample of CDTAs, as not all of the protocols had expired and 
were in need of renewal. 
 
Retail and Independent Pharmacy CDTAs 
Immunization protocols include VFC (Vaccine for Children) 3, 
adolescent and adult routine preventative care, travel shots 
and free vaccine for adults (VFA).  VFA is an additional 
collaborative effort with Merck® Vaccine and Sanofi® vaccine. 
The Merck Patient Assistance Program (MV-PAP) melds a  
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pharmacy, a local health department and Merck® who 
provides free vaccine for eligible adults that are uninsured or 
under insured.4 Sanofi® provides free vaccine and supplies via 
the three-way collaboration between the pharmacy, local 
health department and Sanofi® through a program called 
Americares®.5  
 
Additional protocols that fit with a travel clinic model include 
Malaria prophylaxis, Traveler’s diarrhea treatment, and 
Motion sickness prevention and treatment. 
 
Prenatal vitamin prescriptions, ECP, Opiate overdose 
(naloxone) nasal spray, Tuberculosis testing, Pink Eye testing 
and treatment, H. Pylori testing and treatment, Rapid Strep 
testing and treatment are additional protocols in effect at 
retail stores.  It is possible for a pharmacist to provide simple 
emergency medical services as a revenue stream at the 
pharmacy level especially in rural areas with limited medical 
access in addition to the distribution of medication, MTM 
services and preventative health screenings.  
 
Hospital System Pharmacists and Closed clinic system CDTAs 
System pharmacists are likely to be exclusively engaged in 
CDTA prescriptive authority with no distribution activities. 
The protocols that follow include initiation of dosing, 
adjusting dosing, reviewing and reconciling medications, 
discontinuing medications, providing antidotes and 
emergency medication responses where needed, usually per 
accepted AHRQ medical guidelines or algorithms. Pharmacists 
order lab tests and adjust doses per physical examination as 
well, setting appointments with patients independent of a 
physician visit. 
 
Additional protocols include Anticoagulation clinics; 
Aminoglycoside dosing; Total Parenteral Nutrition (TPN) 
management and compounding; Hospice and Palliative Care; 
Diabetes, Hypertension and Lipid management; Vancomycin 
dosing; Renal dosing; HIV therapy management; Anemia 
management; Transplant medication management; Mental 
Health management (depression, schizophrenia, bipolar, 
mania, addiction)  and  Seizure management including seizure 
kits. 
 
Hospice and Palliative Care can be further broken down into 
several sub-protocols that include Alteration in skin integrity, 
Anxiety, Bowel care (constipation and diarrhea), Cough, 
Depression due to end of life issues, Dyspnea, Elevated 
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temperature (fever), Eye care, Heartburn/reflux/belching, 
hiccups, Itching (pruritus), IV line care, Narcotic induced 
sedation, Nasal congestion, Nausea and Vomiting 
(opioid/narcotic  related nausea), Nutrition, Oral care 
(candida, mucositis, herpes/cold sores, cancer 
sores/stomatitis, dry mouth), Pain, Pediatric pathways, 
Perianal pain (candidiasis, hemorrhoidal, perineal 
discomfort), Sedation for comfort, Sleep pattern disturbance, 
Terminal care, Thrombocytopenia, and Urinary symptoms 
(bladder spasms/infection, urinary incontinence).  
 
Many hospital and clinic systems rely on a team of 
pharmacists to refill medications for system patients, as this 
popular protocol exists for most systems in Washington State. 
 
As of July 1, 2014, the state of Kansas joined the other 48 
states and Washington, D.C in a nationwide trend towards 
advancing the practice of pharmacists who wish to utilize 
their doctor of pharmacy (PharmD) degrees to improve drug 
therapy and healthy outcomes for their patients.6  
 
In contrast pharmacists in the UK under the National Health 
System have two avenues for prescriptive authority as 
supplementary prescribing (SP) introduced in 2003 or 
independent prescribing (IP) introduced in 2006.7 
Supplemental prescribing and collaborative drug therapy 
agreements are generally equivalent practices with American 
pharmacists moving to advance practice degrees and 
specialties as the health care system environment changes. 
The UK offers an advanced practice degree deemed the 
Masters Advanced Pharmacy Practice degree (PgDip/MSc) 
that makes a pharmacist qualified to be a Pharmacist 
Independent Prescriber.8 
 
Conclusion 
 The current practice of clinical pharmacists in the State of 
Washington reflects a professional practice at the level of 
dependent prescriptive authority. Pharmacists are valued 
members of a team of providers taking the role of medication 
specialist providers. Insurance companies recognize this value 
as prescriptions written by pharmacists are covered entities. 
Furthering pharmacist’s credibility into prescribing can be 
supported by a comparable advanced master’s degree 
offered to our UK counterparts. 
 
For twenty three years, Washington State has recognized the 
value of pharmacist’s interventions via the CDTA regulations. 
There are approximately 6300 registered in- state 
pharmacists who also provide advanced patient-centered 
services such as coordination of medications during care 
transitions, medication management, comprehensive 
medication reviews with ongoing medication monitoring, 
chronic disease management, disease education, prevention 
and wellness services, and patient education.9  For patients to 
achieve the full benefit of their medications, pharmacists 
must be part of the health care team as pharmacy practice 
advances from distributing pills to managing ills. 
 
Further outcome research concerning the impact in patient 
care would be the next interesting step as pharmacists take 
responsibility for medication selection, monitoring and 
management.  
 
References 
1. Washington State Legislature page. RCW 18.64.011. 
http://apps.leg.wa.gov/rcw/default.aspx?cite=18.64.
011 Accessed 5/25/2014. 
2. Washing State Legislature Page.  WAC 246-863-110. 
http://apps.leg.wa.gov/wac/default.aspx?cite=246-
863-110 Accessed 5/25/2014.  
3. CDC Website. Vaccine for Children Program page. 
http://www.cdc.gov/vaccines/programs/vfc/index.ht
ml  Accessed 5/25/2014.   
4. Merck Patient Assistance Program webpage. 
http://www.merckhelps.com/MPAP/ Accessed 
5/25/3014.  
5. Americares.org. Medical Outreach page. 
http://www.americares.org/global-health/medical-
outreach/ Accessed 5/25/2014.  
6. American Pharmacists Association webpage. Kansas 
collaborative practice becomes law July 1. 
http://www.pharmacist.com/kansas-collaborative-
practice-law-becomes-effective-july-1-1 Accessed 
7/5/2014.  
7. Tonna AP, Stewart D, West B, McCaig D. Pharmacist 
prescribing in the UK - a literature review of current 
practice and research. J Clin Pharm Ther. 2007 
Dec;32(6):545-56. 
8. Robert Gordon University Aberdeen website. 
Masters Advanced pharmacy Practice Degree 
webpage. http://www.rgu.ac.uk/health-
professions/study-options/part-time-
learning/advanced-pharmacy-practice. Accessed 
7/5/2014. 
9. American Pharmacists Association webpage. 
Provider status: What pharmacists need to know 
now. http://www.pharmacist.com/provider-status-
what-pharmacists-need-know-now Accessed 
5/25/2014. 
http://z.umn.edu/INNOVATIONS                  2014, Vol. 5, No. 3, Article 172                               INNOVATIONS in pharmacy   2 
 
